NASH patients also had significantly elevated plasma alanine transaminase (ALT), aspartate aminotransferase (AST) and triglycerides, with reduced high-density-lipoprotein (HDL)-cholesterol. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.